Pharmacokinetics and Relative Bioavailability of Simvastatin Tablets in Healthy Volunteers
Jing Liu
Abstract
Jing Liu
Abstract
Objective:To establish LC/MS/MS method for determination of Simvastatin in plasma and to study the pharmacokinetics and relative bioavailability following oral administration of trail Simvastatin tablets and reference simvastatin tablets in Chinese healthy volunteers.Methods:Eighteen volunteers were randomly divided into 2 groups.A LC-MS-MS method was used for the determination of Simvastatin in plasma after a single oral dose of 40 mg Simvastatin trail or reference samples in a crossover design.The pharmacokinetic parameters as well as relative bioavailability were analyzed based on a non-compartment model of DAS2.0 statistical software,variation analysis and a two-sided t-test.Results:The main pharmacokinetic parameters of Simvastatin test and reference tablets were as follows:cmax:(9.70±6.62),(10.06±6.29) μg/L;tmax:(1.64±1.01),(1.64±0.68)h;t1/2:(3.48±1.16),(4.15±1.90) h;AUC0~14 h:(29.96±16.28),(32.78±18.53) μg·h·L-1;AUC0~∞ :(31.49±16.65),(36.39±21.71) μg·h·L-1respectively.The relative bioavailability of the test to reference tablets was(97.79±26.63)%.Conclusion:The two preparations are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To establish LC/MS/MS method for determination of Simvastatin in plasma and to study the pharmacokinetics and relative bioavailability following oral administration of trail Simvastatin tablets and reference simvastatin tablets in Chinese healthy volunteers.Methods:Eighteen volunteers were randomly divided into 2 groups.A LC-MS-MS method was used for the determination of Simvastatin in plasma after a single oral dose of 40 mg Simvastatin trail or reference samples in a crossover design.The pharmacokinetic parameters as well as relative bioavailability were analyzed based on a non-compartment model of DAS2.0 statistical software,variation analysis and a two-sided t-test.Results:The main pharmacokinetic parameters of Simvastatin test and reference tablets were as follows:cmax:(9.70±6.62),(10.06±6.29) μg/L;tmax:(1.64±1.01),(1.64±0.68)h;t1/2:(3.48±1.16),(4.15±1.90) h;AUC0~14 h:(29.96±16.28),(32.78±18.53) μg·h·L-1;AUC0~∞ :(31.49±16.65),(36.39±21.71) μg·h·L-1respectively.The relative bioavailability of the test to reference tablets was(97.79±26.63)%.Conclusion:The two preparations are bioequivalent.
Key concepts: Simvastatin, Bioequivalence, Bioavailability, Pharmacokinetics, Cmax, Pharmacology, Crossover study, Medicine